Riskpilot← Back to searchSign inGet full accessHumerus Oy
OYDissolvedY-tunnus 2226319-4Lehmustie 1Medical specialists activities · NACE 8622Est. 20082 employees
Revenue 2024
EUR 3K
-97% vs 2023
EBITDA margin
-130.6%
-183% vs 2023
Equity ratio
88.4%
Financial strength
Net profit 2024
EUR -4K
-110% vs 2023
| Revenue | EUR 3K | -97% |
| EBITDA | EUR -4K | -183% |
| Net profit | EUR -4K | -110% |
| Total assets | EUR 14K | -26% |
| Equity | EUR 13K | -25% |
| Employees | 2 | — |
Legal name
Humerus Oy
Y-tunnus number
2226319-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. lokakuuta 2008
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on lääketieteen koulutustoiminta, lääketieteellisten palveluiden tuottaminen ja terveydenhuoltoalan tarvikkeiden kauppa. Yhtiö voi myös omistaa kiinteää ja irtainta omaisuutta sekä käydä arvopaperikauppaa ja harjoittaa sijoitus- ja vuokraustoimintaa.
Address
Lehmustie 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 196 | 187 | 199 | 194 | 118 | 3 |
| Staff expenses | −101 | −90 | −94 | −91 | −53 | −0 |
| EBITDA | −18 | −15 | −30 | −2 | 5 | −4 |
| Depreciation & amort. | −3 | −2 | −2 | −1 | −1 | −0 |
| EBIT | −22 | −18 | −32 | −3 | 4 | −4 |
| Net financials | −0 | −0 | −0 | −0 | 40 | −0 |
| Profit before tax | −22 | −18 | −32 | −3 | 44 | −4 |
| Tax | −0 | −0 | −0 | 0 | 0 | −0 |
| Net profit | −22 | −18 | −32 | −4 | 44 | −4 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 164 | 143 | 99 | 90 | 19 | 14 |
| Equity | 140 | 111 | 70 | 61 | 17 | 13 |
| Long-term debt | — | — | — | — | 0 | 0 |
| Short-term debt | 23 | 31 | 29 | 29 | 2 | 2 |
| Total debt | 23 | 31 | 29 | 29 | 2 | 2 |
EBITDA margin
-130.6%
This company
15.8%
Market median
-927% vs market
20192024
Equity ratio
88.4%
This company
38.2%
Market median
+131% vs market
20192024
Return on equity
-33.2%
This company
18.4%
Market median
-280% vs market
20192024
Net profit margin
-133.6%
This company
8.1%
Market median
-1749% vs market
20192024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20192024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JN Deputy Member | Deputy Member | 2008 | — | — |
VO Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Humerus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Niina Tuulikki Tanner | Deputy Member | 0 companies |
| Ville Oskari Äärimaa | Chief Executive Officer | 0 companies |